P1.109. Overexpression of RFC3 Relates to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma

Clicks: 18
ID: 326184
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #323 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Topic Esophageal Cancer: Molecular Biology/Pathology Background Replication factor C (activator 1) 3 (RFC3), located on 13q13.2, is reported to be necessary for the elongation of primed DNA templates by DNA polymerase delta and DNA polymerase epsilon. In this study, we tested whether RFC3 acts as a cancer-promoting factor by being overexpressed in esophageal squamous cell carcinoma (ESCC). Methods We analyzed 14 ESCC cell lines and 58 primary tumor samples of ESCC, which were curatively resected in our hospital. Results RFC3 protein was detected in all cell lines and primary tumor samples (39/58 cases; 67.2%). Knockdown of RFC3 using specific siRNA inhibited proliferation in TE-5 and TE-9 of which RFC3 overexpressed strongly. Overexpression of RFC3 protein correlated with lymphatic invasion and worth prognosis. Moreover, multivariate analysis demonstrated that RFC3 was independently associated with worse outcome (p= 0.027, hazard ratio 3.4 (11-15)). Conclusion These findings suggest that RFC3 plays a crucial role in tumor cell proliferation by its overexpression and highlight its usefulness as a prognostic factor and potential therapeutic target in ESCC.
Reference Key
openalex_W7204002495 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.257
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.